1990
DOI: 10.1016/0305-7372(90)90037-g
|View full text |Cite
|
Sign up to set email alerts
|

Novel anthracycline analogs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
22
0

Year Published

1992
1992
2010
2010

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(24 citation statements)
references
References 7 publications
2
22
0
Order By: Relevance
“…The preferential intracellular uptake of MMDX over that of doxorubicin has also been demonstrated by the direct measurement of intracellular drug concentrations (Grandi et al, 1990). MMDX is relatively more lipophilic than doxorubicin (Ripamonti et al, 1992 (Streeter et al.…”
Section: Alkaline and Neutral Elutionsmentioning
confidence: 97%
See 1 more Smart Citation
“…The preferential intracellular uptake of MMDX over that of doxorubicin has also been demonstrated by the direct measurement of intracellular drug concentrations (Grandi et al, 1990). MMDX is relatively more lipophilic than doxorubicin (Ripamonti et al, 1992 (Streeter et al.…”
Section: Alkaline and Neutral Elutionsmentioning
confidence: 97%
“…Methoxymorpholinyl doxorubicin (MMDX) or FCE 23762 is a morpholinyl analogue possessing a methoxymorpholinyl group at the 3' position of the sugar moiety (Figure 1). MMDX is at least 80 times more potent than doxorubicin against P388 leukaemia in vivo, but only 3-to 4-fold more potent than doxorubicin in vitro (Grandi et al, 1990). This compound also maintains in vitro and in vivo cytotoxic activity against P388 leukaemia resistant to doxorubicin (Ripamonti et al, 1992).…”
mentioning
confidence: 99%
“…In both cases, activity on MDR cells is obtained because drugs have been made able to reach cytotoxic intracellular levels. Anthracyclines are an important class of clinically effective anti-tumour drugs, and much effort has been devoted to collecting structure-activity data in relation to their effect on MDR cells (Grandi et al, 1990b).…”
mentioning
confidence: 99%
“…Among these, one of the most promising appears to be the class of morpholino anthracyclines, which were found to possess high effectiveness in vivo, as well as in vitro, on DX-resistant tumours (Watanabe et al, 1988;Grandi et al, 1990b).…”
mentioning
confidence: 99%
See 1 more Smart Citation